Common use of Celgene Clause in Contracts

Celgene. As between the Parties (including their respective Affiliates), Celgene (or its Affiliate) will retain all right, title and interest in and to all Celgene IP, including all rights to Prosecute and Maintain, and enforce any such Celgene IP, and no rights or licenses are granted to Prothena hereunder with respect to any Celgene IP.

Appears in 5 contracts

Sources: Global License Agreement (Prothena Corp Public LTD Co), u.s. License Agreement (Prothena Corp Public LTD Co), Master Collaboration Agreement

Celgene. As between the Parties (including their respective Affiliates), Celgene (or its Affiliate) will retain all right, title and interest in and to all Celgene IP and Celgene Antibody IP, including all rights to Prosecute and Maintain, and enforce or defend any such Celgene IP and Celgene Antibody IP, and no rights or licenses are granted to Prothena hereunder with respect to any Celgene IP or Celgene Antibody IP.

Appears in 1 contract

Sources: Global License Agreement (Prothena Corp Public LTD Co)

Celgene. As between the Parties (including their respective Affiliates)Parties, Celgene (or its Affiliate) will retain all right, title and interest in and to all Celgene IP, Background IP (including all rights to Prosecute and Maintain, and enforce any such Celgene Background IP), and and, no rights or licenses are granted to Prothena Company hereunder with respect to any Celgene Background IP, except, in each case, as stated in Section 7.2.

Appears in 1 contract

Sources: Master Collaboration Agreement (Ikena Oncology, Inc.)

Celgene. As between the Parties (including their respective Affiliates), Celgene (or its Affiliate) will retain all right, title and interest in and to all Celgene IP, including all rights to Prosecute and Maintain, and enforce any such Celgene IP, and no rights or licenses are granted to Prothena hereunder with respect to any Celgene IP. [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

Appears in 1 contract

Sources: Master Collaboration Agreement